Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
UR Pathology Professor David G. Hicks, M.D., a national leader in using molecular technology to diagnose breast cancer, helped to design a new tool to assist other U.S. pathologists in how to personalize treatment for patients with invasive disease.
7/31/2014 | 0 comments
Military troops take doxycycline to prevent infections and malaria, and teenagers use it to treat acne. Wilmot Cancer Institute scientists are also testing it for the treatment of lymphoma.
7/24/2014 | 0 comments
A bit of summer trivia: After George H. Whipple won the 1934 Noble Prize for his discoveries regarding anemia, what happened to his original, handwritten notes?
7/17/2014 | 0 comments
UR scientist Lisa Beck, M.D., led a clinical investigation for a new drug to treat eczema or atopic dermatitis, with encouraging results that were reported in the New England Journal of Medicine.
7/10/2014 | 0 comments
Antibiotics given to preterm newborns disrupt the diversity of gut bacteria, but a shorter, two-day course of drugs has less impact than seven days or more of antibiotics, according to a study from a team in Pediatrics at UR Medicine’s Golisano Children’s Hospital.
7/2/2014 | 1 comment